Baird Financial Group’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.01M Sell
171,014
-13,382
-7% -$269K ﹤0.01% 905
2025
Q4
$3.64M Sell
184,396
-13,425
-7% -$241K 0.01% 834
2025
Q3
$3.45M Sell
197,821
-18,540
-9% -$275K 0.01% 863
2025
Q2
$3.03M Buy
216,361
+180,018
+495% +$2.9M 0.01% 880
2025
Q1
$677K Buy
36,343
+8,351
+30% +$125K ﹤0.01% 1296
2024
Q4
$315K Buy
+27,992
New +$327K ﹤0.01% 1537

Other funds holding ALHC

Baird Financial Group's ALHC Position: Q1 2026 in Review

Baird Financial Group reduced its Alignment Healthcare (ALHC) stake by 7.3% in Q1 2026, selling an estimated $269K and leaving 171,014 shares worth $3.01M. The position accounts for ﹤0.01% of the portfolio, ranked #905.

Baird Financial Group first reported a position in ALHC in Q4 2024 and has held it in 6 quarters since. The position peaked at $3.64M in Q4 2025. 293 funds tracked by Wall St. Rank hold ALHC as of Q1 2026.

  • Baird Financial Group held 171,014 shares of Alignment Healthcare worth $3.01M as of Q1 2026.
  • Baird Financial Group sold 13,382 Alignment Healthcare shares in Q1 2026, an estimated $269K.
  • Alignment Healthcare made up ﹤0.01% of Baird Financial Group's portfolio in Q1 2026, its #905 holding.
  • Baird Financial Group first reported a position in Alignment Healthcare in Q4 2024 and has held it in 6 quarters since.
  • Baird Financial Group's Alignment Healthcare position peaked at $3.64M in Q4 2025.
  • 293 funds tracked by Wall St. Rank held Alignment Healthcare as of Q1 2026.

Based on Baird Financial Group's 13F filing for Q1 2026, filed 14 May 2026.